Type: Session Therapeutic: Pediatrics,Psychiatry,Mental Health
Thursday May 10 11:25am to 12:25pm Location: Lecture Hall 1 Credits: 1 Mainpro+
Depression is a common and serious condition that frequently presents to primary care
practitioners. As a chronic condition, effective early intervention is critical to minimizing
morbidity and mortality lifelong. Primary care practitioners who are knowledgeable and
facilitate treatment of depression can have a tremendous impact in improving the lives of
children and families under their care. This seminar will present current knowledge
regarding the treatment of depressive disorders among children and adolescents. The
seminar will provide participants with a treatment algorithm to consider when managing
children and adolescents with depressive disorders.
Understand the evidence for efficacy of common treatments for depressive disorders.
Appreciate new or emerging treatments for these disorders.
Learn a simple treatment algorithm for the management of early-onset depression in the office setting.
Daphne Korczak MD, MSc, FRCPC (Paeds), FRCPC (Psych) Dr. Korczak is the Director of the Children's Integrated Mood and Body (CLIMB) Depression Program, Psychiatrist and Clinician-Researcher in the Department of Psychiatry at the Hospital for Sick Children in Toronto. Her research focuses on the study of depression in children and adolescents, the biopsychosocial pathways subserving the association between depression and cardiometabolic disorders, and cardiovascular disease, and novel interventions for depression and its associated conditions. Dr. Korczak is the Chair of the Youth Suicide Prevention Working Group at the Centre for Brain and Mental health at Sick Kids, Vice President of the Mental Health Section for the Canadian Paediatric Society,
and a past member of the CPS Mental Health and Developmental Disabilities Committee. As an active educator and advocate for children's mental health, she is committed to increasing the accessibility of mental health information for clinicians, and has authored position statements regarding the use of pharmacotherapy in childhood depression and anxiety, and suicide risk assessment.